CYTEIR THERAPEUTICS

CYT Insider Trades:
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2024-03-20
2024-03-25
LEONARD BRADEN MICHAEL
P - Purchase
Common Stock, par value $0.001 per share
171K
$3.00
512K
1
$96.83M
2024-03-18
2024-03-19
LEONARD BRADEN MICHAEL
P - Purchase
Common Stock, par value $0.001 per share
114K
$3.00
341K
1
$96.83M
2024-03-04
2024-03-05
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Common Stock
6,304
$2.00
12,608
1
$96.83M
2024-03-04
2024-03-05
GAIERO DAVID
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-2,373
$0.00
1
$96.83M
2024-03-04
2024-03-05
GAIERO DAVID
Chief Financial Officer
M - Exercise
Common Stock
2,373
$2.00
4,746
1
$96.83M
2024-03-04
2024-03-05
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Stock Option (Right to Buy)
-6,304
$0.00
1
$96.83M
2024-02-29
2024-03-05
GAIERO DAVID
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-7,985
$0.00
2
$96.83M
2024-02-29
2024-03-05
GAIERO DAVID
Chief Financial Officer
M - Exercise
Common Stock
7,985
$2.00
15,970
2
$96.83M
2024-02-29
2024-03-05
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Stock Option (Right to Buy)
-15,144
$0.00
2
$96.83M
2024-02-29
2024-03-05
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Common Stock
15,144
$2.00
30,288
2
$96.83M
2024-02-14
2024-02-16
GEORGE JEAN
M - Exercise
Common Stock
14,150
$2.00
28,300
1
$96.83M
2024-02-14
2024-02-16
GEORGE JEAN
M - Exercise
Stock Option (Right to Buy)
-14,150
$0.00
1
$96.83M
2024-02-09
2024-02-14
SANDS STEPHEN
M - Exercise
Common Stock
12,129
$2.00
24,258
1
$96.83M
2024-02-09
2024-02-14
SANDS STEPHEN
M - Exercise
Stock Option (Right to Buy)
-12,129
$0.00
1
$96.83M
2024-02-08
2024-02-12
THERO JOHN
M - Exercise
Common Stock
12,828
$2.00
25,656
1
$96.83M
2024-02-08
2024-02-12
THERO JOHN
M - Exercise
Stock Option (Right to Buy)
-12,828
$0.00
1
$96.83M
2024-02-06
2024-02-08
ZAKRZEWSKI JOSEPH
M - Exercise
Common Stock
14,150
$2.00
28,300
1
$96.83M
2024-02-06
2024-02-08
ZAKRZEWSKI JOSEPH
M - Exercise
Stock Option (Right to Buy)
-14,150
$0.00
1
$96.83M
2023-12-11
2023-12-14
GAIERO DAVID
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-3,993
$0.00
2
$96.83M
2023-12-11
2023-12-14
GAIERO DAVID
Chief Financial Officer
M - Exercise
Common Stock
3,993
$2.00
7,986
2
$96.83M
2023-12-11
2023-12-14
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Stock Option (Right to Buy)
-8,840
$0.00
2
$96.83M
2023-11-20
2023-12-14
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Common Stock
8,840
$2.00
17,680
2
$96.83M
2023-11-20
2023-11-22
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Stock Option (Right to Buy)
-84,637
$0.00
2
$96.83M
2023-11-20
2023-11-22
GAIERO DAVID
Chief Financial Officer
M - Exercise
Common Stock
73,940
$2.00
148K
2
$96.83M
2023-11-20
2023-11-22
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Common Stock
84,637
$2.00
169K
2
$96.83M
2023-11-20
2023-11-22
GAIERO DAVID
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-73,940
$0.00
2
$96.83M
2023-07-20
2023-07-20
NOVO HOLDINGS A/S
S - Sale
Common Stock
-100K
$3.00
-300K
1
$96.83M
2023-07-19
2023-07-20
NOVO HOLDINGS A/S
S - Sale
Common Stock
-1,900
$3.00
-5,700
1
$96.83M
2023-07-18
2023-07-18
NOVO HOLDINGS A/S
S - Sale
Common Stock
-6,500
$3.00
-19,500
1
$96.83M
2023-07-17
2023-07-18
NOVO HOLDINGS A/S
S - Sale
Common Stock
-21,100
$3.00
-63,300
1
$96.83M
2023-07-14
2023-07-18
NOVO HOLDINGS A/S
S - Sale
Common Stock
-11,000
$3.00
-33,000
1
$96.83M
2023-07-14
2023-07-14
NOVO HOLDINGS A/S
S - Sale
-2.99M
$3.00
-8.96M
1
$96.83M
2023-06-30
2023-07-03
NOVO HOLDINGS A/S
S - Sale
Common Stock
-201K
$3.00
-603K
1
$96.83M
2023-06-30
2023-06-30
SECRIST JOHN PAUL
Chief Scientific Officer
S - Sale
-18,182
$3.00
-54,546
1
$96.83M
2023-06-28
2023-06-28
SECRIST JOHN PAUL
Chief Scientific Officer
S - Sale
-13,181
$2.00
-26,362
1
$96.83M
2023-06-27
2023-06-28
NOVO HOLDINGS A/S
S - Sale
Common Stock
-31,978
$2.00
-63,956
1
$96.83M
2023-06-26
2023-06-28
NOVO HOLDINGS A/S
S - Sale
Common Stock
-8,437
$2.00
-16,874
1
$96.83M
2023-06-23
2023-06-23
NOVO HOLDINGS A/S
S - Sale
Common Stock
-3,423
$2.00
-6,846
1
$96.83M
2023-06-22
2023-06-23
NOVO HOLDINGS A/S
S - Sale
Common Stock
-5,041
$2.00
-10,082
1
$96.83M
2023-06-21
2023-06-23
NOVO HOLDINGS A/S
S - Sale
Common Stock
-4,834
$2.00
-9,668
1
$96.83M
2023-06-20
2023-06-20
NOVO HOLDINGS A/S
S - Sale
Common Stock
-744
$2.00
-1,488
1
$96.83M
2023-06-16
2023-06-20
NOVO HOLDINGS A/S
S - Sale
Common Stock
-5,983
$2.00
-11,966
1
$96.83M
2023-06-15
2023-06-20
NOVO HOLDINGS A/S
S - Sale
Common Stock
-10,002
$2.00
-20,004
1
$96.83M
2023-06-14
2023-06-14
NOVO HOLDINGS A/S
S - Sale
Common Stock
-2,872
$2.00
-5,744
1
$96.83M
2023-06-13
2023-06-14
NOVO HOLDINGS A/S
S - Sale
Common Stock
-2,626
$2.00
-5,252
1
$96.83M
2023-06-12
2023-06-14
NOVO HOLDINGS A/S
S - Sale
Common Stock
-900
$2.00
-1,800
1
$96.83M
2023-06-12
2023-06-12
NOVO HOLDINGS A/S
S - Sale
-355K
$2.00
-710K
1
$96.83M
2023-02-03
2023-02-07
RENSCHLER MARKUS MD
President and CEO
A - Grant
Stock Option (Right to Buy)
303K
$0.00
1
$96.83M
2023-02-03
2023-02-07
BRACKEN RACQUEL
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2023-02-03
2023-02-07
GAIERO DAVID
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
114K
$0.00
1
$96.83M
2023-02-03
2023-02-07
GEORGE JEAN
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2023-02-03
2023-02-07
HUMPHREY JEFFREY
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2023-02-03
2023-02-07
MOLINEAUX SUSAN
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2023-02-03
2023-02-07
ROMBERGER TIMOTHY
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2023-02-03
2023-02-07
SANDS STEPHEN
A - Grant
Stock Option (Right to Buy)
12,129
$0.00
1
$96.83M
2023-02-03
2023-02-07
THERO JOHN
A - Grant
Stock Option (Right to Buy)
12,828
$0.00
1
$96.83M
2023-02-03
2023-02-07
VENESS ADAM
General Counsel
A - Grant
Stock Option (Right to Buy)
96,100
$0.00
1
$96.83M
2023-02-03
2023-02-07
ZAKRZEWSKI JOSEPH
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2023-01-13
2023-02-07
RENSCHLER MARKUS MD
President and CEO
A - Grant
Common Stock
5,000
$1.00
5,000
1
$96.83M
2023-01-13
2023-02-07
GAIERO DAVID
Chief Financial Officer
A - Grant
Common Stock
5,000
$1.00
5,000
1
$96.83M
2021-12-20
2023-02-07
GAIERO DAVID
Chief Financial Officer
M - Exercise
Common Stock
4,100
$2.00
8,200
1
$96.83M
2021-12-20
2023-02-07
GAIERO DAVID
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-4,100
$0.00
1
$96.83M
2022-12-21
2022-12-23
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Stock Option (Right to Buy)
-137K
$0.00
2
$96.83M
2022-12-21
2022-12-23
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Common Stock
137K
$1.00
137K
2
$96.83M
2022-12-07
2022-12-08
ZAKRZEWSKI JOSEPH
P - Purchase
Common Stock
21,202
$1.00
21,202
1
$96.83M
2022-07-20
2022-07-22
NOVO HOLDINGS A/S
S - Sale
COMMON STOCK
-900K
$3.00
-2.70M
1
$96.83M
2022-05-12
2022-05-16
ZAKRZEWSKI JOSEPH
P - Purchase
Common Stock
743
$2.00
1,486
1
$96.83M
2022-05-11
2022-05-12
ZAKRZEWSKI JOSEPH
P - Purchase
Common Stock
1,000
$2.00
2,000
1
$96.83M
2022-05-10
2022-05-12
THERO JOHN
P - Purchase
Common Stock
10,000
$2.00
20,000
1
$96.83M
2022-05-10
2022-05-12
ZAKRZEWSKI JOSEPH
P - Purchase
Common Stock
49,406
$2.00
98,812
1
$96.83M
2022-05-02
2022-05-04
VENESS ADAM
General Counsel
A - Grant
Stock Option (Right to buy)
177K
$0.00
1
$96.83M
2022-02-22
2022-02-24
SANDS STEPHEN
A - Grant
Stock Option (Right to Buy)
28,300
$0.00
1
$96.83M
2022-02-22
2022-02-24
SECRIST JOHN PAUL
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
42,000
$0.00
1
$96.83M
2022-02-22
2022-02-24
ZAKRZEWSKI JOSEPH
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2022-02-22
2022-02-24
BRACKEN RACQUEL
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2022-02-22
2022-02-24
GAIERO DAVID
Vice President, Finance
A - Grant
Stock Option (Right to Buy)
23,000
$0.00
1
$96.83M
2022-02-22
2022-02-24
GENGOS ANDREW
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
35,000
$0.00
1
$96.83M
2022-02-22
2022-02-24
GEORGE JEAN
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2022-02-22
2022-02-24
HUMPHREY JEFFREY
A - Grant
Stock Option (Right to Buy)
2,358
$0.00
1
$96.83M
2022-02-22
2022-02-24
MOLINEAUX SUSAN
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2022-02-22
2022-02-24
NAESENS JANWILLEM
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2022-02-22
2022-02-24
RENSCHLER MARKUS MD
President and CEO
A - Grant
Stock Option (Right to Buy)
106K
$0.00
1
$96.83M
2022-02-22
2022-02-24
ROMBERGER TIMOTHY
A - Grant
Stock Option (Right to Buy)
14,150
$0.00
1
$96.83M
2022-02-04
2022-02-07
THERO JOHN
A - Grant
Stock Option (Right to Buy)
28,300
$0.00
1
$96.83M
2021-12-28
2021-12-28
ZAKRZEWSKI JOSEPH
P - Purchase
Common Stock
601
$10.00
6,010
1
$96.83M
2021-12-27
2021-12-28
ZAKRZEWSKI JOSEPH
P - Purchase
Common Stock
299
$10.00
2,990
2
$96.83M
2021-12-23
2021-12-28
ZAKRZEWSKI JOSEPH
P - Purchase
Common Stock
200
$10.00
2,000
1
$96.83M
2021-12-17
2021-12-21
ZAKRZEWSKI JOSEPH
P - Purchase
Common Stock
200
$10.00
2,000
1
$96.83M
2021-12-15
2021-12-16
HUMPHREY JEFFREY
A - Grant
Stock Option (Right to Buy)
28,300
$0.00
1
$96.83M
2021-12-15
2021-12-15
ZAKRZEWSKI JOSEPH
P - Purchase
Common Stock
3,700
$11.00
40,700
2
$96.83M
2021-06-22
2021-06-24
DROIA INVEST II SCSP
C - Conversion
Common Stock
3.26M
1
$96.83M
2021-06-22
2021-06-24
GEORGE JEAN
C - Conversion
Series B Convertible Preferred Stock
-7.50M
1
$96.83M
2021-06-22
2021-06-24
GEORGE JEAN
C - Conversion
Series C Convertible Preferred Stock
-832K
1
$96.83M
2021-06-22
2021-06-24
GEORGE JEAN
C - Conversion
Common Stock
2.44M
1
$96.83M
2021-06-22
2021-06-24
DROIA INVEST II SCSP
P - Purchase
Common Stock
278K
$18.00
5.00M
1
$96.83M
2021-06-22
2021-06-24
ROMBERGER TIMOTHY
C - Conversion
Common Stock
79,060
1
$96.83M
2021-06-22
2021-06-24
DROIA INVEST II SCSP
C - Conversion
Series B Convertible Preferred Stock
-10M
1
$96.83M
2021-06-22
2021-06-24
NAESENS JANWILLEM
C - Conversion
Series B Convertible Preferred Stock
-10M
1
$96.83M
2021-06-22
2021-06-24
NAESENS JANWILLEM
C - Conversion
Series C Convertible Preferred Stock
-1.11M
1
$96.83M
2021-06-22
2021-06-24
NAESENS JANWILLEM
C - Conversion
Common Stock
3.26M
1
$96.83M
2021-06-22
2021-06-24
ROMBERGER TIMOTHY
C - Conversion
Series A Convertible Preferred Stock
-69,503
1
$96.83M
2021-06-22
2021-06-24
ROMBERGER TIMOTHY
C - Conversion
Series B Convertible Preferred Stock
-200K
1
$96.83M
2021-06-22
2021-06-24
NAESENS JANWILLEM
P - Purchase
Common Stock
278K
$18.00
5.00M
1
$96.83M
2021-06-22
2021-06-24
ZAKRZEWSKI JOSEPH
C - Conversion
Series B Convertible Preferred Stock
-200K
1
$96.83M
2021-06-22
2021-06-24
ZAKRZEWSKI JOSEPH
C - Conversion
Common Stock
58,671
1
$96.83M
2021-06-22
2021-06-24
DROIA INVEST II SCSP
C - Conversion
Series C Convertible Preferred Stock
-1.11M
1
$96.83M
2021-06-22
2021-06-23
NOVO HOLDINGS A/S
C - Conversion
SERIES C CONVERTIBLE PREFERRED STOCK
-1.55M
1
$96.83M
2021-06-22
2021-06-23
VENROCK ASSOCIATES VII, L.P.
C - Conversion
Common Stock
3.26M
1
$96.83M
2021-06-22
2021-06-23
VENROCK ASSOCIATES VII, L.P.
C - Conversion
Series C Convertible Preferred Stock
-1.11M
1
$96.83M
2021-06-22
2021-06-23
NOVO HOLDINGS A/S
P - Purchase
COMMON STOCK
278K
$18.00
5.00M
1
$96.83M
2021-06-22
2021-06-23
NOVO HOLDINGS A/S
C - Conversion
SERIES B CONVERTIBLE PREFERRED STOCK
-14M
1
$96.83M
2021-06-22
2021-06-23
VENROCK ASSOCIATES VII, L.P.
C - Conversion
Series B Convertible Preferred Stock
-10M
1
$96.83M
2021-06-22
2021-06-23
NOVO HOLDINGS A/S
C - Conversion
COMMON STOCK
4.56M
1
$96.83M